Page last updated: 2024-08-21

pyrazines and formazans

pyrazines has been researched along with formazans in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kotoula, V; McMillin, D; Miller, JW; Mitsiades, CS; Mitsiades, N; Negri, J; Poulaki, V1
Kim, SG; Shin, SM1
Guo, S; Li, X; Qu, F; Tian, C; Xia, B; Yu, Y; Zhang, L; Zhang, Y1

Other Studies

3 other study(ies) available for pyrazines and formazans

ArticleYear
The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Boronic Acids; Bortezomib; Caspases; Cell Proliferation; Flow Cytometry; Formazans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Indicators and Reagents; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Protease Inhibitors; Pyrazines; Retinal Neoplasms; Retinoblastoma; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Tumor Cells, Cultured; Up-Regulation

2007
Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.
    Molecular pharmacology, 2009, Volume: 75, Issue:1

    Topics: Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Formazans; Humans; In Situ Nick-End Labeling; Iron; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Pyrazines; Reactive Oxygen Species; Tetrazolium Salts; Thiones; Thiophenes; Time Factors

2009
[Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Formazans; Humans; Lymphoma, Mantle-Cell; MAP Kinase Signaling System; Neoplasm Proteins; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Purines; Pyrazines; Quinazolinones; Signal Transduction; Software; Tetrazolium Salts

2015